Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Effect of glucose concentration on the stability of daptomycin in peritoneal solutions.

Parra MA, Campanero MA, Sádaba B, Irigoyen A, García-López L, Fernandez-Reyes MJ, Azanza JR.

Perit Dial Int. 2013 Jul-Aug;33(4):458-61. doi: 10.3747/pdi.2012.00120. No abstract available.

PMID:
23843594
2.

[Glucose polymer (icodextrin) as a component of fluid for peritoneal dialysis].

Czyzewska K, Szary B, Grzegorzewska A.

Pol Arch Med Wewn. 1998 May;99(5):417-22. Review. Polish. No abstract available.

PMID:
9816893
3.

[Glucose polymer in the long dwell exchanges in peritoneal dialysis--advantages and limitations].

Olszowska A.

Pol Merkur Lekarski. 2008 Apr;24(142):355-8. Review. Polish.

PMID:
18634373
4.

Icodextrin metabolites in peritoneal dialysis.

García-López E, Lindholm B.

Perit Dial Int. 2009 Jul-Aug;29(4):370-6. Review. No abstract available.

PMID:
19602601
5.

[Results of experimental and clinical investigations on icodextrin --review of studies presented in Charlotte (02/28-03/02/1999)].

Grzegorzewska AE.

Pol Arch Med Wewn. 1999 May;101(5):459-63. Review. Polish. No abstract available.

PMID:
10740428
6.

Ten years after MIDAS: icodextrin lights and shadows.

Amici G, Da Rin G, Agostini A, Velo S, Bocci C.

Contrib Nephrol. 2003;(140):76-81. Review. No abstract available.

PMID:
12800346
7.

Kinetic analysis of peritoneal fluid and solute transport with combination of glucose and icodextrin as osmotic agents.

Galach M, Werynski A, Waniewski J, Freida P, Lindholm B.

Perit Dial Int. 2009 Jan-Feb;29(1):72-80.

PMID:
19164256
8.

Peritoneal transport with icodextrin solution.

Heimbürger O.

Contrib Nephrol. 2006;150:97-103. Review.

PMID:
16720998
10.

Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.

Posthuma N, ter Wee PM, Donker AJ, Oe PL, Peers EM, Verbrugh HA.

Perit Dial Int. 2000;20 Suppl 2:S106-13.

PMID:
10911654
11.

Icodextrin: a review of its use in peritoneal dialysis.

Frampton JE, Plosker GL.

Drugs. 2003;63(19):2079-105. Review.

PMID:
12962523
12.

Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.

Ueda Y, Miyata T, Goffin E, Yoshino A, Inagi R, Ishibashi Y, Izuhara Y, Saito A, Kurokawa K, Van Ypersele De Strihou C.

Kidney Int. 2000 Dec;58(6):2518-24.

PMID:
11115086
13.

[Icodextrin in peritoneal dialysis therapy].

Grzegorzewska AE, Antczak-Jedrzejczak D.

Przegl Lek. 1999;56(12):812-6. Review. Polish.

PMID:
10789195
14.

Icodextrin modeling error with PD ADEQUEST, version 2.0.

Amici G, Da Rin G, Bocci C.

Perit Dial Int. 2001 Sep-Oct;21(5):516-8. No abstract available.

PMID:
11757837
15.

Metabolic consequences of peritoneal dialysis.

Burkart J.

Semin Dial. 2004 Nov-Dec;17(6):498-504. Review.

PMID:
15660581
16.

Daptomycin compatibility in peritoneal dialysis solutions.

Peyro Saint Paul L, Albessard F, Gaillard C, Debruyne D, Ryckelynck JP, Coquerel A, Lobbedez T.

Perit Dial Int. 2011 Jul-Aug;31(4):492-5. doi: 10.3747/pdi.2010.00183. No abstract available.

PMID:
21799057
17.

Potential hazards of polyglucose.

Diaz-Buxo JA, Passlick-Deetjen J, Gotloib L.

ASAIO J. 2001 Nov-Dec;47(6):602-7. Review. No abstract available.

PMID:
11730195
18.

Optimal use of glucose polymer (icodextrin) in peritoneal dialysis.

Mistry CD, Gokal R.

Perit Dial Int. 1996;16 Suppl 1:S104-8. Review.

PMID:
8728173
19.

Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis.

García-López E, Pawlaczyk K, Anderstam B, Qureshi AR, Kuzlan-Pawlaczyk M, Heimbürger O, Werynski A, Lindholm B.

Perit Dial Int. 2007 Jul-Aug;27(4):415-23.

PMID:
17602150
20.

Linezolid stability in peritoneal dialysis solutions.

Manley HJ, McClaran ML, Bedenbaugh A, Peloquin CA.

Perit Dial Int. 2002 May-Jun;22(3):419-22. No abstract available.

PMID:
12227405

Supplemental Content

Support Center